Biologics and Biosimilars

Biography

Marcus Mreyen is an expert for peptide and protein analysis with a focus on mass spectrometric techniques. He holds a PhD in chemistry and spent two years in Australia were he worked in the protein analytical field at Macquarie University and the Australian Proteome Facility (APAF). Starting at Protagen in 2000 he successfully worked as a Project Manager and supported customer projects in the various protein fields. He transferred and deepen his technical understanding during a time working for Shimadzu, one of the worldwide leading analytical instrument provider, as a Product Manager for the Mass Spectrometry and Life Science products. During this time he supported customer in pharma and biotech in Europe and Russia, before returning to Protagen´s Protein Services Unit as a Director Business Development, a company serving now over 180 international clients as CRO to support the development of new protein therapeutics and biosimilars from early phases of discovery, production to GMP release testing.

Abstract

Abstract : CMC Consideration for Biosimilar Drug Development and Manufacturing Process